Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SADIRE malaria treatment and transmission study in Ethiopia
PACTR202508867423098Phase 4Not yet recruiting
- Sponsor
- Gates Foundation
- Start
- Aug 2025
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of artemether, lumefantrine, primaquine, dihydroartemisinin and piperaquine in Malaria (2 arms), sponsored by Gates Foundation. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
artemetherlumefantrineprimaquinedihydroartemisininpiperaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR202508867423098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202508867423098.